Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Brain Tumor Drugs Industry?

The market size for brain tumor medications has seen a robust expansion in the past few years. Its growth is projected to escalate from $3.81 billion in 2024 to $4.03 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.8%. This growth over the historic period can be linked to the rise in the occurrence of neurological disorders, augmented healthcare expenditure, an upsurge in the approval of oncology (cancer) drugs, an increase in expenditures on pharmaceutical R&D, and advancements in cancer drug discovery.

The market size for drugs treating brain tumors is predicted to experience robust growth in the upcoming years, escalating to “$5.16 billion in 2029 with a compound annual growth rate (CAGR) of 6.4%.” The predicted growth during the forecast period is due, in part, to an increasing rate of cancer occurrences, more spending in the healthcare sector, a growing aging population, a promising gamut of drugs in the pipeline, and updated FDA regulations that ease biologic drug development. Key trends for the forecast period encompass investing in a drug mix for treating brain tumors, resorting to the application of phase zero clinical trials to enhance effectiveness, adopting technology for drug delivery that optimizes the drug’s impact, emphasizing the broadening of cell and gene therapy, and executing tactical alliances and amalgamations.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2588&type=smp

What Forces Are Driving The Growth Of The Brain Tumor Drugs Industry?

One of the main catalysts propelling the brain tumor drugs market’s growth is the escalating occurrence of Neurological Disorders across the globe. These disorders are amongst the most common, due to factors like extended life expectancy, higher exposure to infections, and inactive lifestyles. For instance, according to the National Brain Tumor Society, approximately 700,000 individuals in the United States are living with a primary brain tumor and about 86,000 new diagnoses are expected. The surge in patients diagnosed with neurological disorders, including brain tumors, is escalating the demand for drugs used in treatment and consequently, driving the growth of the brain tumor drugs market.

The brain tumor drugs market covered in this report is segmented –

1) By Drugs: Temozolomide, Bevacizumab, Other Drugs

2) By End User: Hospital Pharmacies, Retail Pharmacies Or Drug Stores, Other End-Users

Subsegments:

1) By Temozolomide: Oral Formulation, Injectable Formulation

2) By Bevacizumab: Monoclonal Antibody Therapy, Combination Therapy With Chemotherapy

3) By Other Drugs: Carmustine, Lomustine, Etoposide, Irinotecan, Novantrone (Mitoxantrone)

What Notable Trends Are Shaping The Direction Of The Brain Tumor Drugs Market?

Firms in the brain tumor drugs market are shifting their focus towards the application of nanotechnology for therapy purposes. This approach utilizes tiny particles to transport a mix of drugs directly to the cancer cells or the tumor. Additionally, this innovation has contributed to a decrease in drug dosage, an extension in product shelf life, and a lowering of toxicity. Several nanodrugs have proven effective in breaching the blood-brain barrier, a major obstacle in brain tumor treatment. Examples are Liposomes nanoparticles that make drug delivery to the heart of cancer cells easier, and if covered with transferrin, they can even penetrate the blood-brain barrier. Notable companies like GE Healthcare, Sigma-Tau Pharmaceuticals Inc., Johnson & Johnson, Merck & Company Inc., Pfizer, Inc., and Celgene Corporation are embracing this ground-breaking technology to enhance existing medication procedures and treatments.

Who Are The Primary Players Operating Across The Global Brain Tumor Drugs Market?

Major companies operating in the brain tumor drugs market include F. Hoffmann-La Roche Ltd, Novartis AG, Amgen Inc., Pfizer Inc., Merck & Co. Inc., CordenPharma, Eisai Co., Ltd., Emcure Pharmaceuticals Limited, Y-mAbs Therapeutics, Roche India, Novartis Oncology, Arlak Biotech, Healthkind Labs Pvt. Ltd., SwisscheM Healthcare Pvt.Ltd, Apikos Pharma, Kolaz Biotech, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Astellas Pharma Inc, Otsuka Pharmaceutical Co., Ltd, Daiichi Pharmaceutical and Sankyo, AQVIDA GmbH, Baxter International Inc. (UK), AstraZeneca plc, GlaxoSmithKline plc, Veropharm, Biocad, Bristol-Myers Squibb, Celon Pharma, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, Sandoz AG, Eurofarma Laboratórios S.A., TUTEUR Argentina, The Takeda Pharmaceutical Company Limited, Pierre Fabre Group, Celnova Pharma, Pfizer S.R.L., Teva Pharmaceutical Industries Ltd., BIOPHARMA-MEA, NeoTX, AID Genomics Limited, Julphar, Sanofi, Novo Nordisk A/S, Bayer, Kitov Pharma Limited, CureTech Ltd., Neopharma, Eurolab, Aspen, Adcock Ingram.

https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report

Which Region Offers The Most Growth Potential For The Brain Tumor Drugs Market Through 2029?

North America was the largest region in the brain tumor drugs market in 2024. Middle East is expected to be the fastest-growing region in the global brain tumor drugs market share during the forecast period. The regions covered in the brain tumor drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2588&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model